Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).
Kobayashi Y, Shimada M, Tamate M, Cho HW, Zhu J, Chou HH, Kajiyama H, Okamoto A, Aoki D, Kang S, Lee JW, Kim JW, Kim JH, Lin Z, Liu J, Wu X, Lai HC, Chang TC, Lai CH, Kim YM, Enomoto T. Kobayashi Y, et al. Among authors: okamoto a. J Gynecol Oncol. 2024 May;35(3):e87. doi: 10.3802/jgo.2024.35.e87. Epub 2024 Apr 3. J Gynecol Oncol. 2024. PMID: 38606827 Free PMC article. Review.
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group.
Shimada M, Yoshihara K, Tanigawa T, Nomura H, Hamanishi J, Fujiwara S, Tanabe H, Kajiyama H, Mandai M, Aoki D, Enomoto T, Okamoto A. Shimada M, et al. Among authors: okamoto a. J Gynecol Oncol. 2023 May;34(3):e62. doi: 10.3802/jgo.2023.34.e62. Epub 2023 Apr 21. J Gynecol Oncol. 2023. PMID: 37116954 Free PMC article. Review.
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO).
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H; Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology. Kobayashi Y, et al. Among authors: okamoto a. J Gynecol Oncol. 2022 Sep;33(5):e61. doi: 10.3802/jgo.2022.33.e61. Epub 2022 Jul 18. J Gynecol Oncol. 2022. PMID: 35882604 Free PMC article.
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
Jiang R, Zhu J, Kim JW, Liu J, Kato K, Kim HS, Zhang Y, Zhang P, Zhu T, Aoki D, Yu A, Chen X, Wang X, Zhu D, Zhang W, Jia H, Shi T, Gao W, Yin S, Feng Y, Xiang L, Okamoto A, Zang R. Jiang R, et al. Among authors: okamoto a. J Gynecol Oncol. 2020 Sep;31(5):e86. doi: 10.3802/jgo.2020.31.e86. J Gynecol Oncol. 2020. PMID: 32808504 Free PMC article.
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M. Machida H, et al. Among authors: okamoto a. J Gynecol Oncol. 2022 Jan;33(1):e3. doi: 10.3802/jgo.2022.33.e3. Epub 2021 Nov 1. J Gynecol Oncol. 2022. PMID: 34783206 Free PMC article.
The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T. Kondo E, et al. Among authors: okamoto a. J Gynecol Oncol. 2020 Nov;31(6):e94. doi: 10.3802/jgo.2020.31.e94. J Gynecol Oncol. 2020. PMID: 33078599 Free PMC article. Clinical Trial.
1,536 results